The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Irritable Bowel Syndrome Medication Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Irritable Bowel Syndrome with Constipation
1.2.3 lrritable Bowel Syndrome with Diarrhea
1.2.4 lrritable Bowel Syndrome with alternating Constipationand Diarrhea
1.3 Market by Application
1.3.1 Global Irritable Bowel Syndrome Medication Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Homecare Settings
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Irritable Bowel Syndrome Medication Market Perspective (2019-2030)
2.2 Irritable Bowel Syndrome Medication Growth Trends by Region
2.2.1 Global Irritable Bowel Syndrome Medication Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Irritable Bowel Syndrome Medication Historic Market Size by Region (2019-2024)
2.2.3 Irritable Bowel Syndrome Medication Forecasted Market Size by Region (2025-2030)
2.3 Irritable Bowel Syndrome Medication Market Dynamics
2.3.1 Irritable Bowel Syndrome Medication Industry Trends
2.3.2 Irritable Bowel Syndrome Medication Market Drivers
2.3.3 Irritable Bowel Syndrome Medication Market Challenges
2.3.4 Irritable Bowel Syndrome Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Irritable Bowel Syndrome Medication Players by Revenue
3.1.1 Global Top Irritable Bowel Syndrome Medication Players by Revenue (2019-2024)
3.1.2 Global Irritable Bowel Syndrome Medication Revenue Market Share by Players (2019-2024)
3.2 Global Irritable Bowel Syndrome Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Irritable Bowel Syndrome Medication Revenue
3.4 Global Irritable Bowel Syndrome Medication Market Concentration Ratio
3.4.1 Global Irritable Bowel Syndrome Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome Medication Revenue in 2023
3.5 Irritable Bowel Syndrome Medication Key Players Head office and Area Served
3.6 Key Players Irritable Bowel Syndrome Medication Product Solution and Service
3.7 Date of Enter into Irritable Bowel Syndrome Medication Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Irritable Bowel Syndrome Medication Breakdown Data by Type
4.1 Global Irritable Bowel Syndrome Medication Historic Market Size by Type (2019-2024)
4.2 Global Irritable Bowel Syndrome Medication Forecasted Market Size by Type (2025-2030)
5 Irritable Bowel Syndrome Medication Breakdown Data by Application
5.1 Global Irritable Bowel Syndrome Medication Historic Market Size by Application (2019-2024)
5.2 Global Irritable Bowel Syndrome Medication Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Irritable Bowel Syndrome Medication Market Size (2019-2030)
6.2 North America Irritable Bowel Syndrome Medication Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Irritable Bowel Syndrome Medication Market Size by Country (2019-2024)
6.4 North America Irritable Bowel Syndrome Medication Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Irritable Bowel Syndrome Medication Market Size (2019-2030)
7.2 Europe Irritable Bowel Syndrome Medication Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Irritable Bowel Syndrome Medication Market Size by Country (2019-2024)
7.4 Europe Irritable Bowel Syndrome Medication Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Irritable Bowel Syndrome Medication Market Size (2019-2030)
8.2 Asia-Pacific Irritable Bowel Syndrome Medication Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Irritable Bowel Syndrome Medication Market Size by Region (2019-2024)
8.4 Asia-Pacific Irritable Bowel Syndrome Medication Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Irritable Bowel Syndrome Medication Market Size (2019-2030)
9.2 Latin America Irritable Bowel Syndrome Medication Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Irritable Bowel Syndrome Medication Market Size by Country (2019-2024)
9.4 Latin America Irritable Bowel Syndrome Medication Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Irritable Bowel Syndrome Medication Market Size (2019-2030)
10.2 Middle East & Africa Irritable Bowel Syndrome Medication Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Irritable Bowel Syndrome Medication Market Size by Country (2019-2024)
10.4 Middle East & Africa Irritable Bowel Syndrome Medication Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bausch Health
11.1.1 Bausch Health Company Detail
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Irritable Bowel Syndrome Medication Introduction
11.1.4 Bausch Health Revenue in Irritable Bowel Syndrome Medication Business (2019-2024)
11.1.5 Bausch Health Recent Development
11.2 Sucampo Pharmaceuticals
11.2.1 Sucampo Pharmaceuticals Company Detail
11.2.2 Sucampo Pharmaceuticals Business Overview
11.2.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome Medication Introduction
11.2.4 Sucampo Pharmaceuticals Revenue in Irritable Bowel Syndrome Medication Business (2019-2024)
11.2.5 Sucampo Pharmaceuticals Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Detail
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Irritable Bowel Syndrome Medication Introduction
11.3.4 Abbott Laboratories Revenue in Irritable Bowel Syndrome Medication Business (2019-2024)
11.3.5 Abbott Laboratories Recent Development
11.4 Lexicon Pharmaceuticals
11.4.1 Lexicon Pharmaceuticals Company Detail
11.4.2 Lexicon Pharmaceuticals Business Overview
11.4.3 Lexicon Pharmaceuticals Irritable Bowel Syndrome Medication Introduction
11.4.4 Lexicon Pharmaceuticals Revenue in Irritable Bowel Syndrome Medication Business (2019-2024)
11.4.5 Lexicon Pharmaceuticals Recent Development
11.5 Salix Pharmaceuticals
11.5.1 Salix Pharmaceuticals Company Detail
11.5.2 Salix Pharmaceuticals Business Overview
11.5.3 Salix Pharmaceuticals Irritable Bowel Syndrome Medication Introduction
11.5.4 Salix Pharmaceuticals Revenue in Irritable Bowel Syndrome Medication Business (2019-2024)
11.5.5 Salix Pharmaceuticals Recent Development
11.6 lronwood Pharmaceuticals
11.6.1 lronwood Pharmaceuticals Company Detail
11.6.2 lronwood Pharmaceuticals Business Overview
11.6.3 lronwood Pharmaceuticals Irritable Bowel Syndrome Medication Introduction
11.6.4 lronwood Pharmaceuticals Revenue in Irritable Bowel Syndrome Medication Business (2019-2024)
11.6.5 lronwood Pharmaceuticals Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Irritable Bowel Syndrome Medication Introduction
11.7.4 GlaxoSmithKline Revenue in Irritable Bowel Syndrome Medication Business (2019-2024)
11.7.5 GlaxoSmithKline Recent Development
11.8 Allergan
11.8.1 Allergan Company Detail
11.8.2 Allergan Business Overview
11.8.3 Allergan Irritable Bowel Syndrome Medication Introduction
11.8.4 Allergan Revenue in Irritable Bowel Syndrome Medication Business (2019-2024)
11.8.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Irritable Bowel Syndrome Medication Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Irritable Bowel Syndrome with Constipation
Table 3. Key Players of lrritable Bowel Syndrome with Diarrhea
Table 4. Key Players of lrritable Bowel Syndrome with alternating Constipationand Diarrhea
Table 5. Global Irritable Bowel Syndrome Medication Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Irritable Bowel Syndrome Medication Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Irritable Bowel Syndrome Medication Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Irritable Bowel Syndrome Medication Market Share by Region (2019-2024)
Table 9. Global Irritable Bowel Syndrome Medication Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Irritable Bowel Syndrome Medication Market Share by Region (2025-2030)
Table 11. Irritable Bowel Syndrome Medication Market Trends
Table 12. Irritable Bowel Syndrome Medication Market Drivers
Table 13. Irritable Bowel Syndrome Medication Market Challenges
Table 14. Irritable Bowel Syndrome Medication Market Restraints
Table 15. Global Irritable Bowel Syndrome Medication Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Irritable Bowel Syndrome Medication Market Share by Players (2019-2024)
Table 17. Global Top Irritable Bowel Syndrome Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome Medication as of 2023)
Table 18. Ranking of Global Top Irritable Bowel Syndrome Medication Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Irritable Bowel Syndrome Medication Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Irritable Bowel Syndrome Medication Product Solution and Service
Table 22. Date of Enter into Irritable Bowel Syndrome Medication Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Irritable Bowel Syndrome Medication Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Irritable Bowel Syndrome Medication Revenue Market Share by Type (2019-2024)
Table 26. Global Irritable Bowel Syndrome Medication Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Irritable Bowel Syndrome Medication Revenue Market Share by Type (2025-2030)
Table 28. Global Irritable Bowel Syndrome Medication Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Irritable Bowel Syndrome Medication Revenue Market Share by Application (2019-2024)
Table 30. Global Irritable Bowel Syndrome Medication Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Irritable Bowel Syndrome Medication Revenue Market Share by Application (2025-2030)
Table 32. North America Irritable Bowel Syndrome Medication Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Irritable Bowel Syndrome Medication Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Irritable Bowel Syndrome Medication Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Irritable Bowel Syndrome Medication Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Irritable Bowel Syndrome Medication Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Irritable Bowel Syndrome Medication Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Irritable Bowel Syndrome Medication Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Irritable Bowel Syndrome Medication Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Irritable Bowel Syndrome Medication Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Irritable Bowel Syndrome Medication Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Irritable Bowel Syndrome Medication Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Irritable Bowel Syndrome Medication Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Irritable Bowel Syndrome Medication Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Irritable Bowel Syndrome Medication Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Irritable Bowel Syndrome Medication Market Size by Country (2025-2030) & (US$ Million)
Table 47. Bausch Health Company Detail
Table 48. Bausch Health Business Overview
Table 49. Bausch Health Irritable Bowel Syndrome Medication Product
Table 50. Bausch Health Revenue in Irritable Bowel Syndrome Medication Business (2019-2024) & (US$ Million)
Table 51. Bausch Health Recent Development
Table 52. Sucampo Pharmaceuticals Company Detail
Table 53. Sucampo Pharmaceuticals Business Overview
Table 54. Sucampo Pharmaceuticals Irritable Bowel Syndrome Medication Product
Table 55. Sucampo Pharmaceuticals Revenue in Irritable Bowel Syndrome Medication Business (2019-2024) & (US$ Million)
Table 56. Sucampo Pharmaceuticals Recent Development
Table 57. Abbott Laboratories Company Detail
Table 58. Abbott Laboratories Business Overview
Table 59. Abbott Laboratories Irritable Bowel Syndrome Medication Product
Table 60. Abbott Laboratories Revenue in Irritable Bowel Syndrome Medication Business (2019-2024) & (US$ Million)
Table 61. Abbott Laboratories Recent Development
Table 62. Lexicon Pharmaceuticals Company Detail
Table 63. Lexicon Pharmaceuticals Business Overview
Table 64. Lexicon Pharmaceuticals Irritable Bowel Syndrome Medication Product
Table 65. Lexicon Pharmaceuticals Revenue in Irritable Bowel Syndrome Medication Business (2019-2024) & (US$ Million)
Table 66. Lexicon Pharmaceuticals Recent Development
Table 67. Salix Pharmaceuticals Company Detail
Table 68. Salix Pharmaceuticals Business Overview
Table 69. Salix Pharmaceuticals Irritable Bowel Syndrome Medication Product
Table 70. Salix Pharmaceuticals Revenue in Irritable Bowel Syndrome Medication Business (2019-2024) & (US$ Million)
Table 71. Salix Pharmaceuticals Recent Development
Table 72. lronwood Pharmaceuticals Company Detail
Table 73. lronwood Pharmaceuticals Business Overview
Table 74. lronwood Pharmaceuticals Irritable Bowel Syndrome Medication Product
Table 75. lronwood Pharmaceuticals Revenue in Irritable Bowel Syndrome Medication Business (2019-2024) & (US$ Million)
Table 76. lronwood Pharmaceuticals Recent Development
Table 77. GlaxoSmithKline Company Detail
Table 78. GlaxoSmithKline Business Overview
Table 79. GlaxoSmithKline Irritable Bowel Syndrome Medication Product
Table 80. GlaxoSmithKline Revenue in Irritable Bowel Syndrome Medication Business (2019-2024) & (US$ Million)
Table 81. GlaxoSmithKline Recent Development
Table 82. Allergan Company Detail
Table 83. Allergan Business Overview
Table 84. Allergan Irritable Bowel Syndrome Medication Product
Table 85. Allergan Revenue in Irritable Bowel Syndrome Medication Business (2019-2024) & (US$ Million)
Table 86. Allergan Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Irritable Bowel Syndrome Medication Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Irritable Bowel Syndrome Medication Market Share by Type: 2023 VS 2030
Figure 3. Irritable Bowel Syndrome with Constipation Features
Figure 4. lrritable Bowel Syndrome with Diarrhea Features
Figure 5. lrritable Bowel Syndrome with alternating Constipationand Diarrhea Features
Figure 6. Global Irritable Bowel Syndrome Medication Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Irritable Bowel Syndrome Medication Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Homecare Settings Case Studies
Figure 11. Irritable Bowel Syndrome Medication Report Years Considered
Figure 12. Global Irritable Bowel Syndrome Medication Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Irritable Bowel Syndrome Medication Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Irritable Bowel Syndrome Medication Market Share by Region: 2023 VS 2030
Figure 15. Global Irritable Bowel Syndrome Medication Market Share by Players in 2023
Figure 16. Global Top Irritable Bowel Syndrome Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome Medication as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Irritable Bowel Syndrome Medication Revenue in 2023
Figure 18. North America Irritable Bowel Syndrome Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Irritable Bowel Syndrome Medication Market Share by Country (2019-2030)
Figure 20. United States Irritable Bowel Syndrome Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Irritable Bowel Syndrome Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Irritable Bowel Syndrome Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Irritable Bowel Syndrome Medication Market Share by Country (2019-2030)
Figure 24. Germany Irritable Bowel Syndrome Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Irritable Bowel Syndrome Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Irritable Bowel Syndrome Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Irritable Bowel Syndrome Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Irritable Bowel Syndrome Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Irritable Bowel Syndrome Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Irritable Bowel Syndrome Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Irritable Bowel Syndrome Medication Market Share by Region (2019-2030)
Figure 32. China Irritable Bowel Syndrome Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Irritable Bowel Syndrome Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Irritable Bowel Syndrome Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Irritable Bowel Syndrome Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Irritable Bowel Syndrome Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Irritable Bowel Syndrome Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Irritable Bowel Syndrome Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Irritable Bowel Syndrome Medication Market Share by Country (2019-2030)
Figure 40. Mexico Irritable Bowel Syndrome Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Irritable Bowel Syndrome Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Irritable Bowel Syndrome Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Irritable Bowel Syndrome Medication Market Share by Country (2019-2030)
Figure 44. Turkey Irritable Bowel Syndrome Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Irritable Bowel Syndrome Medication Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Bausch Health Revenue Growth Rate in Irritable Bowel Syndrome Medication Business (2019-2024)
Figure 47. Sucampo Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome Medication Business (2019-2024)
Figure 48. Abbott Laboratories Revenue Growth Rate in Irritable Bowel Syndrome Medication Business (2019-2024)
Figure 49. Lexicon Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome Medication Business (2019-2024)
Figure 50. Salix Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome Medication Business (2019-2024)
Figure 51. lronwood Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome Medication Business (2019-2024)
Figure 52. GlaxoSmithKline Revenue Growth Rate in Irritable Bowel Syndrome Medication Business (2019-2024)
Figure 53. Allergan Revenue Growth Rate in Irritable Bowel Syndrome Medication Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed